Higher expression of HSP110 usually serves as a poor prognostic factor in cases of patients with melanoma, tongue squamous cell carcinoma, non-Hodgkin lymphoma, MDS, AML, gastric or esophageal cancers [97,107,108,109,110,111,112]. The gene discussed is HSPH1; the disease is melanoma.